Skip to search formSkip to main contentSkip to account menu

TRK 530

Known as: TRK-530 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
It has been reported that the pharmacological characteristics of bisphosphonates vary depending on the side chain attached to the… 
Review
2008
Review
2008
This Forum Minireview contains the proceedings of the symposium at the 80th Annual meeting of The Japanese Pharmacological… 
2004
2004
BACKGROUND A newly developed bisphosphonate, TRK-530 (disodium dihydrogen[4-(methylthio)phenylthio]methanebisphosphonate), has… 
2002
2002
  • 2002
  • Corpus ID: 13148379
Introduction; Osteolysis around joint prostheses is reported to be caused by osteoclastic bone resorption, which stimulated by… 
1998
1998
TRK-530 is a novel bisphosphonate derivative. We examined the anti-inflammatory effects of TRK-530 on adjuvant arthritis (AA… 
1998
1998
TRK-530 is a novel synthetic bisphosphonate compound which exhibits inhibitory activity in the rat adjuvant arthritis (AA) model… 
1998
1998
TRK-530, a newly synthesized bisphosphonate, was assessed for its effects on the accumulation of superoxide anions derived from… 
1997
1997
TRK-530 is a newly synthesized diphosphonate derivative. We investigated the effect of TRK-530 on type II collagen-induced…